Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Why This Well-Timed Strategy is Forcing Them to Re-evaluate a Junior Oil Play in Texas

By Prodigy NewsG2 Energy Corp. is a Canadian, publicly-traded company (CSE:GTOO,OTCQB:GTGEF, FKN:UD9) focused on identifying and developing OVERLOOKED opportunities in the energy sector.The...

5 Ways Tech Startups can Compete with the Industry Leaders

It is a common thing for any established industry to be dominated by several large companies. There are eBay and Amazon for eCommerce, Facebook and Snapchat for social media, Uber and Lyft for transportation, etc. Beating such competitors is a tough challenge every ...

The Detailed Anatomy of the S&P 500 Upswing

Today’s extensive article will evaluate the week that just passed, and examine the health of the S&P 500 advance. We’ll look both at various credit market metrics, and at the key S&P 500 sectors and ratios. Putting the pieces of the puzzle toget...

Ovid Therapeutics Posts Positive Data from Phase 2 Seizure Reduction Trial

Ovid Therapeutics' shares are trading 25% higher today after the company reported positive initial data from its ENDYMION soticlestat phase 2 trial for patients with developmental and epileptic encephalopathies. Shares of Ovid Therapeutics Inc. (OVID:NASDAQ) are tra...

Why Did ImmunoGen Plummet 32%?

This biotechnology company, which focuses on the treatment of cancer, received some feedback from the FDA that upset investors on Wednesday. ImmunoGen Inc.'s (IMGN:NASDAQ) shares closed down 32.06% on the NASDAQ Wednesday after announcing the United States ...

PDS Biotech Collaborating with Merck in Phase 2 Cancer Trial

This morning PDS Biotechnology Corp. shares are trading 38% higher after reporting that it will enter into a clinical collaboration with Merck pairing the firm's PDS0101 with KEYTRUDA for patients with recurrent or metastatic head and neck cancer and high-risk HPV16 infection....

Trillion Energy’s (CSE:TCF) Bayhanli-2 gas well enters production

Trillion Energy International Inc. ( CSE: TCF ) ( OTCQB: TRLEF ) (Frankfurt: Z62) announced flow test results for the Bayhanli-2 natural gas well at the SASB gas field, offshore Turkey. Eight intervals of gas pay with a true thickness of about 21 metres were perfor...

Cabral Sitting on a Plateau of Gold

I fully approve of garimpeiro miners. Rarely can they read and write. They can live under conditions that the majority of us could never handle. They mine in a totally different way than do the junior resource companies in the space. They all make money. That's right, 100...

Rally or New Bull Market?

In recent days the market has moved from expecting a rate cut by January 2020 to now expecting as much as three rate cuts by then. As a result both Gold and gold stocks launched higher, forming a “three white soldiers” bullish reversal pattern. Last w...

Silver Continues Upswing, Pushes Above 17.00

Silver continues to its slow-but-sure upward move. The metal posted gains of 2.1% last week and has crossed above the symbolic $17.00 level. Kenny Fisher Silver prices have started the new trading week with g...
1 2 3 4 5 6 7 8 9 10 ...
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse